{
    "nctId": "NCT02996240",
    "briefTitle": "Breast, Omega 3 Free Fatty Acid, Ph 0",
    "officialTitle": "A Phase 0, Investigator Initiated Study, Evaluating the Impact of Omega 3 Free Fatty Acid Supplementation on Breast Cancer (CTMS# 16-0119)",
    "overallStatus": "COMPLETED",
    "conditions": "Breastcancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 21,
    "primaryOutcomeMeasure": "Change in serum colony stimulating factor at surgery",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* At least 18 years of age\n* ECOG \u22642\n* Ability to understand the purposes and risks of the study and has signed a written informed consent form approved by the investigator's IRB/Ethics Committee\n* Consented for tissue collection on CTRC repository 07-32\n\nExclusion Criteria:\n\n* Active systemic illness (infection including viral illnesses such as Hepatitis and HIV)\n* Chronic use of NSAIDs or omega-3 free fatty acid supplementation within the last 60 days (defined as greater than or equal to 7 consecutive days)\n* Any NSAIDs or omega-3 free fatty acid supplementation within the last 14 days\n* History of medical noncompliance\n* Scheduled date of surgical resection that would limit the amount of time taking the intervention to less than 21 days",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}